Related Experiment Video
Updated: Dec 28, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
Author Correction: Engineering Axl specific CAR and SynNotch receptor for cancer therapy
Jang Hwan Cho1,2, Atsushi Okuma1,2, Dalal Al-Rubaye1,2,3
1Department of Biomedical Engineering, Boston University, Boston, MA, 02215, USA.
Abstract:
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
More Related Videos
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
08:04In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy